vialroom

#retatrutide 2026-03-15

Sunday16 messages5 participantstimes are UTC
Highlights from this day
  • step_one_sian — held at 10 for 14 months and it never plateaued for me, which i cant explain low and slow here means smaller steps than i ever used on tirzepatide, thats the received… 16:25
  • step_one_sian — buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely 16:37
  • step_one_sian — follow up the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 16:38
  • VialBot — Inter-lab diff for lot B-0114: 99% vs 96.8%. Within expected range. 16:39
  • step_one_sian — quick one appetite suppression at 0.5 was stronger than my tirzepatide experience at a comparable point 17:01
LN

GI was about the same as tirzepatide for me, the difference was how fast it arrived, i could be wrong

held at 10 for 14 months and it never plateaued for me, which i cant explain
low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom

SO

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

follow up the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

VB

Inter-lab diff for lot B-0114: 99% vs 96.8%. Within expected range.

👍5❤️5
SO

quick one appetite suppression at 0.5 was stronger than my tirzepatide experience at a comparable point

*Medutest not the other one

TT

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

follow up research use only is on every vial and i treat it as exactly that, nobody here is prescribing

i said 7 months ago that my heart rate had settled and it has stayed settled since